Jiangsu Haici Biological Pharmaceutical Co., Ltd., a wholly-owned subsidiary invested by Yangtze River Pharmaceutical Group in 2004, is located in Binjiang Industrial Park, Medical New & Hi-tech Industrial Development Zone. It is the research and development, pilot test and production base of chemical API of the Group. It is mainly engaged in the technical research, production and sales of high value-added APIs and pharmaceutical intermediates.The company has accumulated 24 product standards that have reached the international leading level, 30 products have been recognized as provincial high-tech products, and 25 national invention patents have been authorized, Many products have been successfully registered and sold in 9 countries.  For example, the company is currently the only domestic company that has mastered the preparation process of tamoxifen citrate crystal form A, making the group the first to pass the consistency evaluation of this product in China and market the product to the international market.
The m...

Related Categories

Sales Markets

Oceania; Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity

Academic/Research; Contract Service; Distributor/Import Export; Licensee; Manufacturer/Innovator

Contact information




View All Contact Info

Categories affiliated with Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co., Ltd.